Glepaglutide (also known as ZP 1848), a long-acting glucagon-like peptide-2 (GLP-2) analog that was developed for patients with reduced or complete loss of intestinal function. In October 2017 - The U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has granted an orphan drug designation to glepaglutide for the treatment of the rare disease short bowel syndrome (SBS). Many people with SBS are dependent on the frequent intake of intravenous fluids and nutrition delivered through a central catheter. Currently, glepaglutide is participating in a phase III clinical trial to determine the safety and efficacy of subcutaneous injection of the drug for the treatment of SBS.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT03905707
Glucagon-Like Peptide-2 (GLP-2) analog, 10 mg subcutaneous injection twice weekly.
Route of Administration:
Other
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
539216
Created by
admin on Fri Dec 15 20:17:51 GMT 2023 , Edited by admin on Fri Dec 15 20:17:51 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C166765
Created by
admin on Fri Dec 15 20:17:51 GMT 2023 , Edited by admin on Fri Dec 15 20:17:51 GMT 2023
|
PRIMARY | |||
|
DB14794
Created by
admin on Fri Dec 15 20:17:51 GMT 2023 , Edited by admin on Fri Dec 15 20:17:51 GMT 2023
|
PRIMARY | |||
|
914009-86-2
Created by
admin on Fri Dec 15 20:17:51 GMT 2023 , Edited by admin on Fri Dec 15 20:17:51 GMT 2023
|
PRIMARY | |||
|
FG-40
Created by
admin on Fri Dec 15 20:17:51 GMT 2023 , Edited by admin on Fri Dec 15 20:17:51 GMT 2023
|
PRIMARY | |||
|
10481
Created by
admin on Fri Dec 15 20:17:51 GMT 2023 , Edited by admin on Fri Dec 15 20:17:51 GMT 2023
|
PRIMARY | |||
|
4M3C1913N6
Created by
admin on Fri Dec 15 20:17:51 GMT 2023 , Edited by admin on Fri Dec 15 20:17:51 GMT 2023
|
PRIMARY |
ACTIVE MOIETY